Stock Price
15,218.00
Daily Change
-108.00 -0.70%
Monthly
10.66%
Yearly
28.08%
Q1 Forecast
14,964.60

AstraZeneca reported $236.76B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Alcon AG USD 29.11B 5.61B Sep/2025
Almirall EUR 2.75B 8.36M Feb/2026
Amgen USD 201.45B 25.2B Feb/2026
argenx SE USD 44.32B 15.63B Sep/2025
AstraZeneca USD 222.33B 65.82B Feb/2026
Autolus Therapeutics Ltd USD 433.81M 172.99M Sep/2025
Bayer EUR 27.23B 2.14B Sep/2025
Biogen USD 27.01B 1.19B Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Eli Lilly USD 1.01T 3.37B Feb/2026
Fresenius EUR 28.86B 2.16B Feb/2026
Fresenius Medical Care EUR 11.19B 770.21M Feb/2026
Galapagos EUR 1.93B 10.54M Feb/2026
Genmab DKK 80.88B 7.82B Jun/2025
Gilead Sciences USD 183.59B 31.31B Feb/2026
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
GRIFOLS EUR 7.49B 1.16B Sep/2025
Haleon GBP 34.31B 671.51M Feb/2026
Hikma Pharmaceutical USD 6.06B 1.64B Jun/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.59B 239.13M Sep/2025
Merck USD 300.37B 39.11B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Orion EUR 7.27B 1.67B Feb/2026
Pfizer USD 152.89B 11.32B Feb/2026
Philips EUR 24.21B 1.83B Feb/2026
Recordati EUR 9.81B 343.76M Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025